Search research articles
Contact Us
Filters
Showing results (111-120 of 299) with videos related to
Page
of 30
Sort By:
Leukemia & Lymphoma
|
January 24, 2004
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group
James Z Huang, Dennis D Weisenburger, Julie M Vose, et al.
Leukemia & Lymphoma
|
August 3, 2002
CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience
Julie M Vose, Dennis D Weisenburger, James C Lynch, et al.
Leukemia & Lymphoma
|
March 9, 2019
Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma
Srinivasa N Gopalsamy, Kristen M Rosenthal, Amy A Ayers, et al.
British Journal of Haematology
|
June 29, 2011
The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin
Myron S Czuczman, Julie M Vose, Thomas E Witzig, et al.
Leukemia & Lymphoma
|
September 17, 2004
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group
James Z Huang, Dennis D Weisenburger, Julie M Vose, et al.
Annals of Hematology
|
October 20, 2021
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
Mridula Krishnan, R Gregory Bociek, Michelle Fanale, et al.
American Journal of Hematology
|
August 5, 2016
Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia
Nabin Khanal, R Gregory Bociek, Baojiang Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study
Fausto R Loberiza, Anthony J Cannon, Dennis D Weisenburger, et al.
Haematologica
|
January 21, 2017
Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas
Chengfeng Bi, Xuan Zhang, Ting Lu, et al.
International Journal of Cancer
|
April 19, 2012
Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling
Ganapati V Hegde, Tara M Nordgren, Corey M Munger, et al.
Page
of 30
Search research articles
Search
Showing results (111-120 of 299) with videos related to
Sort By:
Page
of 30
Leukemia & Lymphoma
|
January 24, 2004
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group
James Z Huang, Dennis D Weisenburger, Julie M Vose, et al.
Leukemia & Lymphoma
|
August 3, 2002
CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience
Julie M Vose, Dennis D Weisenburger, James C Lynch, et al.
Leukemia & Lymphoma
|
March 9, 2019
Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma
Srinivasa N Gopalsamy, Kristen M Rosenthal, Amy A Ayers, et al.
British Journal of Haematology
|
June 29, 2011
The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin
Myron S Czuczman, Julie M Vose, Thomas E Witzig, et al.
Leukemia & Lymphoma
|
September 17, 2004
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group
James Z Huang, Dennis D Weisenburger, Julie M Vose, et al.
Annals of Hematology
|
October 20, 2021
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
Mridula Krishnan, R Gregory Bociek, Michelle Fanale, et al.
American Journal of Hematology
|
August 5, 2016
Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia
Nabin Khanal, R Gregory Bociek, Baojiang Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study
Fausto R Loberiza, Anthony J Cannon, Dennis D Weisenburger, et al.
Haematologica
|
January 21, 2017
Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas
Chengfeng Bi, Xuan Zhang, Ting Lu, et al.
International Journal of Cancer
|
April 19, 2012
Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling
Ganapati V Hegde, Tara M Nordgren, Corey M Munger, et al.
Page
of 30